← All trends
Confidence: StrongAs of 2026-07-10
global · market pattern
GLP-1 family: 26.8M searches a month
The GLP-1 family draws about 26.8M searches a month across 30 markets. Awareness sits in the class term GLP-1, but purchase demand concentrates in the brands, led by Mounjaro.
The GLP-1 boom, mapped as one family: how awareness in the class term turns into demand for specific brands.
What it isthe full GLP-1 weight-loss family: the drug class plus its branded members.
Working hypothesisAI-suggested
The class term GLP-1 captures awareness; the money and purchase intent live in the branded members, Mounjaro and Ozempic lead. Read the family to see the whole funnel.
The evidence
- family total
- about 26.8M searches a month across the family, summed over 30 markets [MEASURED, upper bound: members overlap]
- awareness vs purchase
- class term GLP-1 = 3.9M/mo (awareness); brand leader Mounjaro = 7.8M/mo (purchase tier) [MEASURED]
- note
- A class term shows awareness alone; its purchase tier lives in the sibling brands. Family totals are an upper bound because members overlap. Search demand, not sales.
The full ranking
8 tracked · GLP-1 family funnel.
- 1Mounjaro7.8M/mo
- 2Ozempic4.7M/mo, -7% 6mo
- 3Glp 13.9M/mo, +10% 6mo
- 4Tirzepatide3.2M/mo, +28% 6mo
- 5Wegovy3M/mo, +9% 6mo
- 6Semaglutide2.1M/mo
- 7Zepbound1.1M/mo, +6% 6mo
- 8Medical Weight Loss973K/mo, +29% 6mo